# ACTAVIA LIFE SCIENCES, INC.

ACTAVIA LIFE SCIENCES, INC. is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** ACTAVIA LIFE SCIENCES, INC.
- **Former names in filing history:** Rasna Therapeutics Inc. (2016-09-27 to 2023-08-14); Active With Me Inc. (2013-09-11 to 2016-09-26)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** NV
- **Fiscal year end:** September 30
- **SEC CIK:** 0001582249

## About

ACTAVIA LIFE SCIENCES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001582249, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-01-05, it reported net income of USD -4,442,535; total assets of USD 95,657 for the fiscal period ended 2023-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-09-30)

- **Net income:** -$4.4M (USD -4,442,535)
- **Total assets:** $95,657 (USD 95,657)
- **Operating cash flow:** -$8,516 (USD -8,516)

### FY2022 (period ended 2022-09-30)

- **Net income:** -$686,588 (USD -686,588)
- **Total assets:** $85,276 (USD 85,276)
- **Operating cash flow:** -$312,663 (USD -312,663)

### FY2021 (period ended 2021-09-30)

- **Net income:** -$785,082 (USD -785,082)
- **Total assets:** $44,577 (USD 44,577)
- **Operating cash flow:** -$293,393 (USD -293,393)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-09-30)

- **Net income:** -$5.3M (USD -5,346,672)
- **Total assets:** $32,944 (USD 32,944)
- **Cash and equivalents:** $14,241 (USD 14,241)
- **Operating cash flow:** -$251,327 (USD -251,327)

## Recent SEC filings

- Form 10-Q — filed 2024-05-20 — period 2024-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2024-04-10 — period 2024-04-04 — CURRENT REPORT
- Form 10-Q — filed 2024-02-16 — period 2023-12-31 — QUARTERLY REPORT
- Form 10-K — filed 2024-01-05 — period 2023-09-30 — ANNUAL REPORT
- Form 8-K — filed 2023-10-26 — period 2023-10-24 — CURRENT REPORT
- Form 10-Q — filed 2023-08-14 — period 2023-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2023-05-15 — period 2023-03-31 — QUARTERLY REPORT
- Form 10-Q — filed 2023-03-02 — period 2022-12-31 — QUARTERLY REPORT
- Form 10-K — filed 2023-02-09 — period 2022-09-30 — ANNUAL REPORT
- Form 8-K — filed 2023-01-23 — period 2023-01-20 — CURRENT REPORT
- Form 8-K — filed 2022-12-20 — period 2022-12-16 — CURRENT REPORT
- Form 10-Q — filed 2022-08-22 — period 2022-06-30 — QUARTERLY REPORT

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/actavia-life-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology